Skip to main content
OpenTrials
Completed

NCT Number: NCT02309294

14-Day Cumulative Irritation Patch Test in Subjects With Normal Skin

The objective of this study is to determine the ability of the study material to cause irritation to the skin of humans under controlled patch test conditions. Substances that come into contact with human skin need to be evaluated for their propensity to irritate and/or sensitize. This testing is a modified primary irritancy patch test that can detect weak irritants that require multiple applications to cause a skin reaction.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

TKL Research, Inc.

Fair Lawn, New Jersey, 07410, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Are a male or female, 18 years of age or older, in general good health;
  • Have normal skin;
  • Are free of any systemic or dermatologic disorder which, in the opinion of the investigative personnel, will interfere with the study results or increase the risk of adverse events;
  • Are of any skin type or race providing the skin pigmentation will allow discernment of erythema;
  • Complete a medical screening procedure; and
  • Read, understand, and sign an informed consent.

Exclusion criteria

  • Have any visible skin disease at the study site which, in the opinion of the investigative personnel, will interfere with the evaluation;
  • Are receiving systematic or topical drugs or medication which, in the opinion of the investigative personnel, will interfere with the study results;
  • Have psoriasis and/or active atopic dermatitis/eczema; and/or
  • Have a known sensitivity to cosmetics, skin care products, or topical drugs as related to the material being evaluated.

Treatment and study plan

Novel lubricant Miami w/ fragrance

Device

0.2 ml aliquot on occlusive patch

Novel lubricant Miami no fragrance

Device

0.2 ml aliquot on occlusive patch

KY Liquid lubricant

Device

0.2 ml aliquot on occlusive patch

Astroglide Gel lubricant

Device

0.2 ml aliquot on occlusive patch

Wet Platinum lubricant

Device

0.2 ml aliquot on occlusive patch

Primary outcomes

  1. Number of Subjects That Showed no Significant Irritation

    Time frame: 14 days

    Score of less than or equal to 1.2 on the Cumulative Irritation Test scale (0-5).

Sponsors and collaborators

Lead sponsor

Church & Dwight Company, Inc.

Industry

Registry information

Important dates

Study start
2014
Primary completion
2014
Study completion
2014
First posted
Dec 5, 2014
Registry last updated
Oct 12, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.